HelixPoint Capital is an investment firm built around AI- and robotics-driven science, with a strategy designed to scale across scientific infrastructure, private markets, and diversified capital vehicles advancing human health.
What We Do
Robots
Robotics that work alongside scientists to increase precision, consistency, and throughput across critical lab operations.
Biotech
Biotech companies we select for their ability to scale with automation, AI, and our global network that move faster toward major financing and clinical milestones.
Infrastructure Design
Flexible, modular, automation-ready lab and data systems that let our companies scale experiments, quality, and decision-making as they grow.
AI
AI used to design experiments, analyze results at scale, and focus capital on the programs most likely to win.
